Search research articles
Contact Us
Filters
Showing results (51-60 of 71) with videos related to
Page
of 8
Sort By:
Cancer Research
|
September 28, 2013
A small-molecule blocking ribonucleotide reductase holoenzyme formation inhibits cancer cell growth and overcomes drug resistance
Bingsen Zhou, Leila Su, Shuya Hu, et al.
Clinical Lymphoma & Myeloma
|
August 2, 2006
Phase I/II trial of nonpegylated liposomal doxorubicin, cyclophosphamide, vincristine, and prednisone in the treatment of newly diagnosed aggressive non-Hodgkin's lymphoma
Anil Tulpule, Byron M Espina, Nancy Berman, et al.
Blood Advances
|
February 24, 2026
Safety, efficacy and patient-reported outcomes 6 years after fidanacogene elaparvovec in adults with hemophilia B
Benjamin J Samelson-Jones, John Ej Rasko, Jonathan Ducore, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 29, 2017
Novel BAFF-Receptor Antibody to Natively Folded Recombinant Protein Eliminates Drug-Resistant Human B-cell Malignancies <i>In Vivo</i>
Hong Qin, Guowei Wei, Ippei Sakamaki, et al.
Academic Pediatrics
|
November 21, 2012
The pediatrics milestones: initial evidence for their use as learning road maps for residents
Daniel J Schumacher, Kadriye O Lewis, Ann E Burke, et al.
The New Zealand Medical Journal
|
June 21, 2022
Effectiveness of a preschool asthma education programme, compared to usual care, on the frequency of acute asthma events: a community-based cluster randomised trial
Natalie Walker, Taina von Blaramberg, Janet Mackay, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition
|
August 23, 2022
Bronchopulmonary dysplasia and neurobehavioural outcomes at birth and 2 years in infants born before 30 weeks
Monika Martin, Lynne Smith, Julie A Hofheimer, et al.
Blood Advances
|
February 14, 2025
Phase 1 trial of durvalumab (anti-PD-L1) combined with lenalidomide in relapsed/refractory cutaneous T-cell lymphoma
Christiane Querfeld, Joycelynne Palmer, Zhen Han, et al.
Pediatric Research
|
July 27, 2023
Maternal perceived stress and infant behavior during the COVID-19 pandemic
Holly Bradley, Dana Fine, Yasmin Minai, et al.
Blood Cancer Journal
|
January 11, 2023
Pevonedistat, a Nedd8-activating enzyme inhibitor, in combination with ibrutinib in patients with relapsed/refractory B-cell non-Hodgkin lymphoma
Pallawi Torka, Swetha Kambhampati Thiruvengadam, Lu Chen, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 71) with videos related to
Sort By:
Page
of 8
Cancer Research
|
September 28, 2013
A small-molecule blocking ribonucleotide reductase holoenzyme formation inhibits cancer cell growth and overcomes drug resistance
Bingsen Zhou, Leila Su, Shuya Hu, et al.
Clinical Lymphoma & Myeloma
|
August 2, 2006
Phase I/II trial of nonpegylated liposomal doxorubicin, cyclophosphamide, vincristine, and prednisone in the treatment of newly diagnosed aggressive non-Hodgkin's lymphoma
Anil Tulpule, Byron M Espina, Nancy Berman, et al.
Blood Advances
|
February 24, 2026
Safety, efficacy and patient-reported outcomes 6 years after fidanacogene elaparvovec in adults with hemophilia B
Benjamin J Samelson-Jones, John Ej Rasko, Jonathan Ducore, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 29, 2017
Novel BAFF-Receptor Antibody to Natively Folded Recombinant Protein Eliminates Drug-Resistant Human B-cell Malignancies <i>In Vivo</i>
Hong Qin, Guowei Wei, Ippei Sakamaki, et al.
Academic Pediatrics
|
November 21, 2012
The pediatrics milestones: initial evidence for their use as learning road maps for residents
Daniel J Schumacher, Kadriye O Lewis, Ann E Burke, et al.
The New Zealand Medical Journal
|
June 21, 2022
Effectiveness of a preschool asthma education programme, compared to usual care, on the frequency of acute asthma events: a community-based cluster randomised trial
Natalie Walker, Taina von Blaramberg, Janet Mackay, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition
|
August 23, 2022
Bronchopulmonary dysplasia and neurobehavioural outcomes at birth and 2 years in infants born before 30 weeks
Monika Martin, Lynne Smith, Julie A Hofheimer, et al.
Blood Advances
|
February 14, 2025
Phase 1 trial of durvalumab (anti-PD-L1) combined with lenalidomide in relapsed/refractory cutaneous T-cell lymphoma
Christiane Querfeld, Joycelynne Palmer, Zhen Han, et al.
Pediatric Research
|
July 27, 2023
Maternal perceived stress and infant behavior during the COVID-19 pandemic
Holly Bradley, Dana Fine, Yasmin Minai, et al.
Blood Cancer Journal
|
January 11, 2023
Pevonedistat, a Nedd8-activating enzyme inhibitor, in combination with ibrutinib in patients with relapsed/refractory B-cell non-Hodgkin lymphoma
Pallawi Torka, Swetha Kambhampati Thiruvengadam, Lu Chen, et al.
Page
of 8